Daily non-political popular news in brief.

Newly identified mechanism for silencing genes points to possible anti-cancer strategies

Scientists are only beginning to appreciate the extraordinary degree of control exercised over every step of the gene-to-protein production process. Only about 10 percent of human genes, for example, are active in a given cell at a given time, with the remaining 90 percent silenced by a various mechanisms. In a just-published study in Nature, scientists report an important new gene-silencing mechanism that points to promising potential targets for anti-cancer interventions.

Read more »

Keywords: newly, identified, mechanism, silencing, genes, points, possible, anti-cancer, strategies, gene, point, anti, cancer, strategy

« Previous | Next »

Similar news on "Newly identified mechanism for silencing genes points to possible anti-cancer strategies":

1. Researchers find the mechanism by which cells resist chemotherapy
   03-02-2007 · EurekAlert!
   A team of researchers from the UAB's Mutagenesis Group, led by Dr. Jordi Surralйs, has identified one of the mechanisms used by cancer cells to resist chemotherapy. This discovery, published in the EMBO Jorunal, will make it possible to develop strategies to make tumors more vulnerable to chemotherapy.
   Similar news · Read more »
   
2. First familial pancreatic cancer gene identified
   12-11-2006 · EurekAlert!
   At least 10 percent of pancreatic cancers are thought to be familial, i.e., caused by inherited genetic mutations. The responsible genes have so far remained elusive, but one of the research teams that had been on a pancreatic cancer gene hunt for years now reports success: Teri Brentnall (University of Washington), David Whitcomb (University of Pittsburgh), and colleagues publish the identification of the palladin gene as the one mutated in a large family they had been studying for a while.
   Similar news · Read more »
   
3. Jefferson scientists see breast cancer gene activity from outside the body
   11-28-2007 · EurekAlert!
   Researchers at Jefferson Medical College and Jefferson's Kimmel Cancer Center in Philadelphia have used PET imaging to see hyperactive cancer genes inside breast tumors in laboratory animals, marking the first time such gene activity has been observed from outside the body. This technology might someday help physicians to detect and classify cancer, enabling them to find cancerous breast tumors as early as possible, and determine the appropriate treatment.
   Similar news · Read more »
   
4. AVN944 inhibits IMPDH & induces apoptosis-related biomarkers in patients with hematologic cancers
   12-11-2006 · EurekAlert!
   IMPDH is highly upregulated in most hematological cancers and solid tumors -- an essential role in cancer cell synthesis of DNA and RNA. Inhibition of IMPDH represents a new and important approach to treat cancer. In a Phase I trial of AVN944, AvalonRx identified a set of 34 genes. These gene markers correlate with the biochemical effects of AVN944 on protein function -- believed to result in tumor cell apoptosis at the right doses.
   Similar news · Read more »
   
5. Unique role for blood formation gene identified
   09-12-2007 · EurekAlert!
   All blood cell production in adults depends on the steady work of a vital gene that if lost results in early bone marrow failure, Dartmouth Medical School cancer geneticists have found. Their research reveals an unexpected role for the gene in sustaining the adult blood-forming system, and opens novel strategies for targeting the gene, which is often involved in a type of childhood leukemia.
   Similar news · Read more »
   
6. Identifying the mechanism behind a genetic susceptibility to type 2 diabetes
   08-01-2007 · EurekAlert!
   Type 2 diabetes is reaching epidemic proportions in the developed world. Determining if and how certain genes predispose individuals to type 2 diabetes is likely to lead to the development of new treatment strategies for individuals with the disease. A new study now shows that certain variants of the gene TCF7L2 make individuals more susceptible to type 2 diabetes and provides a mechanism by which these genetic variants might cause susceptibility to the disease.
   Similar news · Read more »
   
7. Silencing Pests: Altered plants make RNA that keeps insects at bay
   11-10-2007 · Science News Online
   Engineered plants make genetic material that disables critical genes in insects that eat the plants, offering a possible new strategy for agricultural-pest control.
   Similar news · Read more »
   
8. Application of Genomatix in silico methods reveals novel cancer associated genes
   03-19-2007 · EurekAlert!
   Genomatix Software GmbH, an in silico systems biology company with headquarter in Munich, Germany, released today that researcher in Dublin, Ireland, and Boston, Mass., USA, identified novel cancer associated genes, based on strategies and products developed and promoted by Genomatix. Experimental verification by siRNA knock-down and RT-PCR confirmed the in silico results.
   Similar news · Read more »
   
9. Analysis of breast and colon cancer genes finds many areas of differences between tumors
   10-11-2007 · EurekAlert!
   Researchers from University Hospitals Ireland Cancer Center and Case Western Reserve University School of Medicine are part of a new national study that has analyzed more than 18,000 genes, including 5,000 previously unmapped genes, from breast and colorectal tumors. The study shows a great number of genetic differences between breast and colon cancer tumors, leading the researchers to conclude that new drugs must be developed that can hit these newly identified genetic targets in a manner specific to each different individual's tumor.
   Similar news · Read more »
   
10. New gene test for prostate cancer at hand
    01-17-2008 · EurekAlert!
    Men with susceptibility for prostate cancer will soon be identifiable through a simple DNA test. So hope scientists at the Swedish medical university Karolinska Institutet, who have shown that men carrying a combination of known risk genes run a four to five times higher risk of developing prostate cancer. At present, men with suspected prostate cancer are identified mainly using what are known as PSA tests. However, the test has a relatively low sensitivity and better methods are needed.
    Similar news · Read more »